KLAS: Analytics becoming a ‘must-have’

Laura Pedulli | | Health Exec | Economics

The need for analytics is growing as healthcare organizations move from volume to value-based care. As a result, vendors are rushing to the market with a wave of new products, including more targeted solutions, according to a report from KLAS, a Utah-based research firm.

KLAS interviewed more than 100 healthcare providers, who reported that the healthcare analytics market is growing rapidly. They cited 87 different vendors offering business intelligence (BI)/analytics tools for value-based care. No single vendor was mentioned more than 7 percent of the time, underscoring that no vendor yet dominates the field.

"Business intelligence and analytics have gone from a 'nice-to-have' to a 'must-have' in today's challenging healthcare environment," said Joe Van De Graaff, report author and research director at KLAS. "To fulfill short-term analytics needs, many providers report shifting more consideration to vendors with healthcare-specific solutions. However, a clear market leader has yet to emerge."

KLAS analyzed a variety of cross industry BI/analytics, healthcare specific and large vendors in its report. To access it, go here.

 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.